Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation

Clinical trial NCT06339775 · RECRUITING

Trial details

NCT number: NCT06339775
Sponsor: Suping ZHANG
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute B-cell Lymphoblastic Leukemia

Start date: 2023-09-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.